GLP-3 RT 12mg Peptides
Engineered for exacting research, this peptide is prepared to deliver consistent, repeatable performance from the first study to the last aliquot.
This GLP-3 RT lyophilized peptide vial is designed for professional laboratory use, providing a clean, dependable GLP-series research material with a total content of 12mg. The lyophilized format supports stability during shipment and storage, offering a straightforward path to reconstitution under your validated laboratory procedures.
- Each vial contains 12mg of GLP-3 RT, supporting advanced investigations into glucagon-like peptide pathways, receptor interaction, structure–activity relationships, and in vitro assay development.
As a non-edible, laboratory-grade peptide, GLP-3 RT is intended for controlled environments where handling precision matters. Researchers may reconstitute according to their protocol and preferred buffer systems to achieve the target concentration for method development, characterization, or comparative analysis. The lyophilized presentation helps preserve integrity prior to reconstitution, while thoughtful handling—minimizing freeze–thaw cycles, avoiding excessive agitation, and working under clean conditions—supports reliable, reproducible results across study runs.
Primavora emphasizes quality from sourcing through fulfillment. Each lot is produced in the USA to rigorous internal specifications, then verified by analytical methods such as HPLC and mass spectrometry for identity and purity. Every vial is lot-coded and traceable, with documentation available to support method validation and audit requirements. Packaging is designed for stability and protection, and our controlled supply chain prioritizes careful temperature management and tamper-evident security for dependable arrival and storage.
Research-use-only: This material is intended exclusively for qualified laboratory research. Not for human or veterinary use, and not for diagnostic, therapeutic, or household purposes. Handle using appropriate laboratory PPE and aseptic technique consistent with institutional guidelines. Store according to your laboratory’s established procedures; protect from light and avoid unnecessary freeze–thaw exposure to maintain material integrity. With Primavora, you can expect disciplined manufacturing, transparent documentation, and a research-focused partner committed to purity, consistency, and reliability.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-3 RT?
GLP-3 RT is not a standard pharmacology name, and on research-vendor sites it is often used as shorthand for a retatrutide-style multi-incretin compound. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.
What is GLP-3 RT typically studied for?
Compounds sold under this label are generally discussed for appetite, glucose regulation, energy expenditure, and multi-receptor incretin signaling. A careful FAQ should avoid presenting the shorthand as if it were a formal drug name and instead tell readers to verify the exact active ingredient before designing research around it.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Prima Vora are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
